|
1
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abstracts from the 38th annual meeting of
the society of general internal medicine. J Gen Intern Med.
30:(Suppl 2). 45–551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Muñoz-Pinedo C, El Mjiyad N and Ricci JE:
Cancer metabolism: Current perspectives and future directions. Cell
Death Dis. 3:e2482012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jain M, Nilsson R, Sharma S, Madhusudhan
N, Kitami T, Souza AL, Kafri R, Kirschner MW, Clish CB and Mootha
VK: Metabolite profiling identifies a key role for glycine in rapid
cancer cell proliferation. Science. 336:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gross S, Cairns RA, Minden MD, Driggers
EM, Bittinger MA, Jang HG, Sasaki M, Jin S, Schenkein DP, Su SM, et
al: Cancer-associated metabolite 2-hydroxyglutarate accumulates in
acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2
mutations. J Exp Med. 207:339–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fiehn O: Metabolomics - the link between
genotypes and phenotypes. Plant Mol Biol. 48:155–171. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song H, Wang L, Liu HL, Wu XB, Wang HS,
Liu ZH, Li Y, Diao DC, Chen HL and Peng JS: Tissue metabolomic
fingerprinting reveals metabolic disorders associated with human
gastric cancer morbidity. Oncol Rep. 26:431–438. 2011.PubMed/NCBI
|
|
12
|
Nicholson JK, Connelly J, Lindon JC and
Holmes E: Metabonomics: A platform for studying drug toxicity and
gene function. Nat Rev Drug Discov. 1:153–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu Y, Cai G, Zhou B, Li D, Zhao A, Xie G,
Li H, Cai S, Xie D, Huang C, et al: A distinct metabolic signature
of human colorectal cancer with prognostic potential. Clin Cancer
Res. 20:2136–2146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jung J, Jung Y, Bang EJ, Cho SI, Jang YJ,
Kwak JM, Ryu H, Park S and Hwang GS: Noninvasive diagnosis and
evaluation of curative surgery for gastric cancer by using
NMR-based metabolomic profiling. Ann Surg Oncol. 21:(Suppl 4).
S736–S742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Song X, Zhao X, Zou L and Xu G:
Serum metabolic profiling study of lung cancer using ultra high
performance liquid chromatography/quadrupole time-of-flight mass
spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci.
966:147–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen C, Deng L, Wei S, Gowda GA Nagana, Gu
H, Chiorean EG, Abu Zaid M, Harrison ML, Pekny JF, Loehrer PJ, et
al: Exploring metabolic profile differences between colorectal
polyp patients and controls using seemingly unrelated regression. J
Proteome Res. 14:2492–2499. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ganti S, Taylor SL, Abu Aboud O, Yang J,
Evans C, Osier MV, Alexander DC, Kim K and Weiss RH: Kidney tumor
biomarkers revealed by simultaneous multiple matrix metabolomics
analysis. Cancer Res. 72:3471–3479. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Griffin JL and Shockcor JP: Metabolic
profiles of cancer cells. Nat Rev Cancer. 4:551–561. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu J, Djukovic D, Deng L, Gu H, Himmati
F, Chiorean EG and Raftery D: Colorectal cancer detection using
targeted serum metabolic profiling. J Proteome Res. 13:4120–4130.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nuñez-Sánchez MA, García-Villalba R,
Monedero-Saiz T, García-Talavera NV, Gómez-Sánchez MB,
Sánchez-Álvarez C, García-Albert AM, Rodríguez-Gil FJ, Ruiz-Marín
M, Pastor-Quirante FA, et al: Targeted metabolic profiling of
pomegranate polyphenols and urolithins in plasma, urine and colon
tissues from colorectal cancer patients. Mol Nutr Food Res.
58:1199–1211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng Y, Xie G, Chen T, Qiu Y, Zou X,
Zheng M, Tan B, Feng B, Dong T, He P, et al: Distinct urinary
metabolic profile of human colorectal cancer. J Proteome Res.
11:1354–1363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Beckonert O, Keun HC, Ebbels TM, Bundy J,
Holmes E, Lindon JC and Nicholson JK: Metabolic profiling,
metabolomic and metabonomic procedures for NMR spectroscopy of
urine, plasma, serum and tissue extracts. Nat Protoc. 2:2692–2703.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu Z, Deng Y, Hu C, Deng P, Bu Q, Yan G,
Zhou J, Shao X, Zhao J, Li Y, et al: ¹H NMR-based metabonomic
analysis of brain in rats of morphine dependence and withdrawal
intervention. Behav Brain Res. 231:11–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Wang L, Zhang H, Deng P, Chen J,
Zhou B, Hu J, Zou J, Lu W, Xiang P, et al: ¹H NMR-based metabolic
profiling of human rectal cancer tissue. Mol Cancer. 12:1212013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Feng J, Liu H, Bhakoo KK, Lu L and Chen Z:
A metabonomic analysis of organ specific response to USPIO
administration. Biomaterials. 32:6558–6569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu Y, Chen T, Fu S, Sun X, Wang L, Wang J,
Lu Y, Ding S, Ruan G, Teng L, et al: Perioperative dynamics and
significance of amino acid profiles in patients with cancer. J
Transl Med. 13:352015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martínez-Zaguilán R, Seftor EA, Seftor RE,
Chu YW, Gillies RJ and Hendrix MJ: Acidic pH enhances the invasive
behavior of human melanoma cells. Clin Exp Metastasis. 14:176–186.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Williams MD, Zhang X, Park JJ, Siems WF,
Gang DR, Resar LM, Reeves R and Hill HH Jr: Characterizing
metabolic changes in human colorectal cancer. Anal Bioanal Chem.
407:4581–4595. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heiden MG Vander, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daye D and Wellen KE: Metabolic
reprogramming in cancer: Unraveling the role of glutamine in
tumorigenesis. Semin Cell Dev Biol. 23:362–369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Holst S, Stavenhagen K, Balog CI, Koeleman
CA, McDonnell LM, Mayboroda OA, Verhoeven A, Mesker WE, Tollenaar
RA, Deelder AM, et al: Investigations on aberrant glycosylation of
glycosphingolipids in colorectal cancer tissues using liquid
chromatography and matrix-assisted laser desorption time-of-flight
mass spectrometry (MALDI-TOF-MS). Mol Cell Proteomics.
12:3081–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ni Y, Xie G and Jia W: Metabonomics of
human colorectal cancer: New approaches for early diagnosis and
biomarker discovery. J Proteome Res. 13:3857–3870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schlappack OK, Zimmermann A and Hill RP:
Glucose starvation and acidosis: Effect on experimental metastatic
potential, DNA content and MTX resistance of murine tumour cells.
Br J Cancer. 64:663–670. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dang CV: Links between metabolism and
cancer. Genes Dev. 26:877–890. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pan T, Gao L, Wu G, Shen G, Xie S, Wen H,
Yang J, Zhou Y, Tu Z and Qian W: Elevated expression of glutaminase
confers glucose utilization via glutaminolysis in prostate cancer.
Biochem Biophys Res Commun. 456:452–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maddocks OD, Berkers CR, Mason SM, Zheng
L, Blyth K, Gottlieb E and Vousden KH: Serine starvation induces
stress and p53-dependent metabolic remodelling in cancer cells.
Nature. 493:542–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Locasale JW, Grassian AR, Melman T,
Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen
T, Sharfi H, et al: Phosphoglycerate dehydrogenase diverts
glycolytic flux and contributes to oncogenesis. Nat Genet.
43:869–874. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Locasale JW and Cantley LC: Genetic
selection for enhanced serine metabolism in cancer development.
Cell Cycle. 10:3812–3813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Possemato R, Marks KM, Shaul YD, Pacold
ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et
al: Functional genomics reveal that the serine synthesis pathway is
essential in breast cancer. Nature. 476:346–350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khan AP, Rajendiran TM, Ateeq B, Asangani
IA, Athanikar JN, Yocum AK, Mehra R, Siddiqui J, Palapattu G, Wei
JT, et al: The role of sarcosine metabolism in prostate cancer
progression. Neoplasia. 15:491–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Baum CE, Price DK and Figg WD: Sarcosine
as a potential prostate cancer biomarker and therapeutic target.
Cancer Biol Ther. 9:341–342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cha YJ, Kim H, Jung WH and Koo JS:
Expression of sarcosine metabolism-related proteins according to
metastatic site in breast cancer. Int J Clin Exp Pathol.
7:7824–7833. 2014.PubMed/NCBI
|
|
43
|
Cha YJ, Jung WH, Cho NH and Koo JS:
Expression of sarcosine metabolism-related proteins in invasive
lobular carcinoma: Comparison to invasive ductal carcinoma. Yonsei
Med J. 56:598–607. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Glunde K, Bhujwalla ZM and Ronen SM:
Choline metabolism in malignant transformation. Nat Rev Cancer.
11:835–848. 2011.PubMed/NCBI
|
|
45
|
Lin JK and Ho YS: Hepatotoxicity and
hepatocarcinogenicity in rats fed squid with or without exogenous
nitrite. Food Chem Toxicol. 30:695–702. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lin PC, Lin JK, Lin CH, Lin HH, Yang SH,
Jiang JK, Chen WS, Chou CC, Tsai SF and Chang SC: Clinical
relevance of plasma DNA methylation in colorectal cancer patients
identified by using a genome-wide high-resolution array. Ann Surg
Oncol. 22:(Suppl 3). S1419–S1427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Michailidi C, Theocharis S, Tsourouflis G,
Pletsa V, Kouraklis G, Patsouris E, Papavassiliou AG and Troungos
C: Expression and promoter methylation status of hMLH1, MGMT, APC,
and CDH1 genes in patients with colon adenocarcinoma. Exp Biol Med
(Maywood). 240:1599–1605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nakamura K, Yamashita K, Sawaki H, Waraya
M, Katoh H, Nakayama N, Kawamata H, Nishimiya H, Ema A, Narimatsu
H, et al: Aberrant methylation of GCNT2 is tightly related to lymph
node metastasis of primary CRC. Anticancer Res. 35:1411–1421.
2015.PubMed/NCBI
|
|
49
|
Hinnebusch BF, Meng S, Wu JT, Archer SY
and Hodin RA: The effects of short-chain fatty acids on human colon
cancer cell phenotype are associated with histone hyperacetylation.
J Nutr. 132:1012–1017. 2002.PubMed/NCBI
|
|
50
|
Lan A, Lagadic-Gossmann D, Lemaire C,
Brenner C and Jan G: Acidic extracellular pH shifts colorectal
cancer cell death from apoptosis to necrosis upon exposure to
propionate and acetate, major end-products of the human probiotic
propionibacteria. Apoptosis. 12:573–591. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Comerford SA, Huang Z, Du X, Wang Y, Cai
L, Witkiewicz AK, Walters H, Tantawy MN, Fu A, Manning HC, et al:
Acetate dependence of tumors. Cell. 159:1591–1602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mashimo T, Pichumani K, Vemireddy V,
Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S, Piccirillo
SG, Kovacs Z, Foong C, et al: Acetate is a bioenergetic substrate
for human glioblastoma and brain metastases. Cell. 159:1603–1614.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen R, Xu M, Nagati JS, Hogg RT, Das A,
Gerard RD and Garcia JA: The acetate/ACSS2 switch regulates HIF-2
stress signaling in the tumor cell microenvironment. PLoS One.
10:e01165152015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Marques C, Oliveira CS, Alves S, Chaves
SR, Coutinho OP, Côrte-Real M and Preto A: Acetate-induced
apoptosis in colorectal carcinoma cells involves lysosomal membrane
permeabilization and cathepsin D release. Cell Death Dis.
4:e5072013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Oliveira CS, Pereira H, Alves S, Castro L,
Baltazar F, Chaves SR, Preto A and Côrte-Real M: Cathepsin D
protects colorectal cancer cells from acetate-induced apoptosis
through autophagy-independent degradation of damaged mitochondria.
Cell Death Dis. 6:e17882015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nogueira V and Hay N: Molecular pathways:
reactive oxygen species homeostasis in cancer cells and
implications for cancer therapy. Clin Cancer Res. 19:4309–4314.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Glasauer A and Chandel NS: Targeting
antioxidants for cancer therapy. Biochem Pharmacol. 92:90–101.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Weinberg F, Hamanaka R, Wheaton WW,
Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger
GR and Chandel NS: Mitochondrial metabolism and ROS generation are
essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA.
107:8788–8793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Moon DO, Kim MO, Choi YH, Hyun JW, Chang
WY and Kim GY: Butein induces G(2)/M phase arrest and apoptosis in
human hepatoma cancer cells through ROS generation. Cancer Lett.
288:204–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fiser B, Szori M, Jójárt B, Izsák R,
Csizmadia IG and Viskolcz B: Antioxidant potential of glutathione:
A theoretical study. J Phys Chem B. 115:11269–11277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Teoh-Fitzgerald ML, Fitzgerald MP, Zhong
W, Askeland RW and Domann FE: Epigenetic reprogramming governs
EcSOD expression during human mammary epithelial cell
differentiation, tumorigenesis and metastasis. Oncogene.
33:358–368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Silani V: Editorial on the original
article entitled ‘Genetic validation of a therapeutic target in a
mouse model of ALS’ published in the Science Translational Medicine
on August 6, 2014. Ann Transl Med. 3:(Suppl 1). S272015.PubMed/NCBI
|
|
63
|
Chiang YT, Yen YW and Lo CL: Reactive
oxygen species and glutathione dual redox-responsive micelles for
selective cytotoxicity of cancer. Biomaterials. 61:150–161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Qiao YL, Dawsey SM, Kamangar F, Fan JH,
Abnet CC, Sun XD, Johnson LL, Gail MH, Dong ZW, Yu B, et al: Total
and cancer mortality after supplementation with vitamins and
minerals: Follow-up of the Linxian General Population Nutrition
Intervention Trial. J Natl Cancer Inst. 101:507–518. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Klein EA, Thompson IM Jr, Tangen CM,
Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL,
Gaziano JM, et al: Vitamin E and the risk of prostate cancer: The
Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA.
306:1549–1556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Brosnan JT and Brosnan ME: Branched-chain
amino acids: Enzyme and substrate regulation. J Nutr. 136:(Suppl).
207S–211S. 2006.PubMed/NCBI
|
|
67
|
Zhu X, Herrera G and Ochoa JB:
Immunosupression and infection after major surgery: A nutritional
deficiency. Crit Care Clin. 26:491–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Phillips MM, Sheaff MT and Szlosarek PW:
Targeting arginine-dependent cancers with arginine-degrading
enzymes: Opportunities and challenges. Cancer Res Treat.
45:251–262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Platten M, Wick W and Van den Eynde BJ:
Tryptophan catabolism in cancer: Beyond IDO and tryptophan
depletion. Cancer Res. 72:5435–5440. 2012. View Article : Google Scholar : PubMed/NCBI
|
